Iksuda Therapeutics Ltd.
Clinical trials sponsored by Iksuda Therapeutics Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New HER2-Targeting drug shows promise in early cancer trial Results expected Dec 2026 (estimated)
- New Antibody-Drug shows promise for Hard-to-Treat lymphoma Results expected Sep 2027 (estimated)